Market Overview:
Blood
coagulant aids in improving the coagulation process of blood in order to stop
bleeding and fastening the healing process. According to the report that has
been published by Market Research Future (MRFR), blood coagulants
market size is expected to reach USD 2.57 billion by 2030 at CAGR 10.90%
during the forecast period 2022-2030
Competitive Landscape:
Increasing
demand for high-quality blood coagulants in the market has led to the
introduction of innovative products by the in the Middle East and Africa blood
coagulants market players. The players are focusing on business expansion by
increasing their research and development expenditure and strategizing mergers
and acquisitions for establishing their products not on in the Middle East and
Africa region but also on a global level.
In
February 2018, it was announced that an Israeli-developed bandage named
WoundClot, a plant-based gauze that stops blood loss within seconds by
stimulating body’s coagulation process, will be sold globally.
The
prominent players that are profiled in the report on the Middle East and Africa
market by MRFR are
Pfizer
Inc. (the U.S.),
Bayer
AG (Germany),
Novo
Nordisk AS (Denmark),
Shire
(Republic of Ireland),
SOBI
(Sweden),
Octapharma
(Switzerland), and
CSL
Limited (Australia).
Market Segmentation:
The
Middle East and Africa blood coagulants
market trends is segmented on the basis of types, indications, and
by country. Based on types, the blood coagulants market is segmented into
coagulation factor and others. Coagulation factor segment is sub-segmented into
recombinant coagulation factor, plasma coagulation factor, and others.
Based
on indication, the blood coagulants market is segmented into hemophilia, surgery,
other bleeding disorders, and others. Hemophilia segment is sub-segmented into
hemophilia A and hemophilia B.
Market Drivers and Restraints:
Increasing
prevalence of bleeding disorders caused by diseases such as hemophilia which
leads to defect in blood coagulation is inducing demand for blood coagulants in
the market in the Middle East and Africa region. The beneficial properties of
blood coagulant drugs or anti-inhibitor coagulant complexes to help regulate
blood coagulation for patients suffering from bleeding disorders are fueling
the growth of the Middle East and Africa blood coagulants market.
Rise
in incidences of major injuries caused due to accidents leading to
uncontrollable bleeding and increasing demand for blood thickening medications
are likely to propel the growth of the blood coagulants market in the Middle
East and Africa region during the forecast period. However, lack of primary
health care services, poor healthcare infrastructure and lack of awareness in
the underdeveloped areas are acting as major restraints on the growth of the
Middle East and Africa blood coagulation market overview during the forecast
period.
Regional Analysis:
The
Middle East and Africa blood coagulants market is geographically segmented into
few major countries such as Saudi Arabia (KSA), United Arab Emirates (UAE),
Qatar, Oman, Kuwait, Egypt, and the rest of the Middle East and Africa.
Saudi
Arabia accounts for the largest share in the Middle East and Africa blood
coagulant market. The high prevalence of hemophilia, increasing usage of
expensive recombinant coagulation factors and high disposable income of the
population, are some of the major factors that are driving the growth of the
blood coagulant market in this country. Whereas, United Arab Emirates (UAE) is
projecting fastest growth in the Middle East and Africa blood coagulants
market.
Increasing
healthcare expenditure and research and development in the field of
anti-inhibitor coagulant complexes are leading to the expansion of the blood
coagulants market in the Middle East and Africa region.
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
No comments:
Post a Comment